Cardiology Clinic Letter

**Diagnoses** 1. Atrial Fibrillation (Paroxysmal) 2. Hypertension (Essential) 3. Dyslipidemia 4. Type 2 Diabetes Mellitus **Current medications:** Metoprolol 50mg daily, Eliquis 5mg twice daily, Atorvastatin 20mg nightly, Metformin 1000mg twice daily, Lisinopril 10mg daily. The patient, Mr. John Smith, a 68-year-old male, was referred by his GP due to recurrent episodes of palpitations and dizziness over the past three months. His initial presentation involved sudden onset of rapid, irregular heartbeats accompanied by lightheadedness, typically lasting a few hours before self-resolving. He has a known history of essential hypertension and type 2 diabetes, both managed medically for several years. The frequency and intensity of his palpitations have increased recently, prompting this cardiology consultation. Mr. Smith has several significant cardiovascular risk factors. He has a history of well-controlled hypertension and type 2 diabetes. Lifestyle factors include a sedentary occupation and occasional alcohol consumption. There is a strong family history of cardiovascular disease, with his father having experienced a myocardial infarction at age 60 and his mother having hypertension. He is a former smoker, having quit 10 years ago. **Investigations performed** 1. Electrocardiogram (ECG): Revealed irregularly irregular rhythm, consistent with atrial fibrillation during symptomatic periods. 2. 24-hour Holter Monitor: Documented multiple episodes of paroxysmal atrial fibrillation, with the longest episode lasting 4 hours and associated with a heart rate up to 160 bpm. 3. Echocardiogram: Showed mild left ventricular hypertrophy, normal ejection fraction (60%), and no significant valvular abnormalities. 4. Blood tests: Included full blood count, electrolytes, renal function tests, liver function tests, thyroid function tests, HbA1c, and lipid profile. All were within normal limits except for a slightly elevated HbA1c (7.1%) and LDL cholesterol (3.2 mmol/L). On examination, Mr. Smith appeared comfortable and in no acute distress. His vital signs were: Blood pressure 138/86 mmHg, heart rate 72 bpm (regular sinus rhythm at time of examination), respiratory rate 16 breaths/min, and oxygen saturation 98% on room air. Cardiovascular examination revealed normal S1 and S2 heart sounds with no murmurs, rubs, or gallops. Peripheral pulses were 2+ bilaterally in all four limbs. Lung fields were clear to auscultation bilaterally. Abdominal examination was soft and non-tender with no organomegaly. There was no peripheral oedema. In summary, Mr. Smith is a 68-year-old male with known hypertension and type 2 diabetes presenting with recurrent paroxysmal atrial fibrillation. Investigations confirm the diagnosis and rule out significant structural heart disease. His symptoms are impacting his quality of life. The current management plan needs to address optimal rate and rhythm control, as well as thorough assessment of stroke risk and optimisation of his existing cardiovascular risk factors. The primary differential diagnoses considered included paroxysmal supraventricular tachycardia (PSVT) and atrial flutter, but the Holter monitor findings were most consistent with atrial fibrillation. **Management plan** 1. **Investigations planned** 1. Cardiac MRI (if further structural assessment required). 2. Repeat Holter monitoring in 3 months. 2. **Future interventions or treatments planned** 1. Discuss antiarrhythmic options (e.g., flecainide, amiodarone) for rhythm control vs. rate control strategy. 2. Initiate shared decision-making regarding potential electrical cardioversion if pharmacological rhythm control fails. 3. Refer to Cardiac Electrophysiology for consideration of catheter ablation if medical management is insufficient. 4. Optimise anti-coagulation with Eliquis; review CHA2DS2-VASc score and confirm patient adherence. 5. Lifestyle modification counselling regarding diet, exercise, and alcohol intake. 6. Review current medications, particularly statin and diabetes management, with his GP for potential dose adjustments to meet target goals. 3. **Contingent future interventions** 1. If episodes of AF become more frequent or persistent, discuss escalation to catheter ablation or direct current cardioversion. 2. If stroke risk increases or patient experiences transient ischaemic attacks (TIAs), reconsider anticoagulation strategy or dosage. 4. **Long-term management strategies** 1. Regular follow-up with cardiology for ongoing monitoring of AF burden and cardiovascular risk factors. 2. Collaborative care with GP for management of hypertension and diabetes. 3. Patient education on AF symptoms, red flags, and adherence to medication and lifestyle changes. 4. Annual review of anticoagulation and overall cardiovascular risk assessment.